Literature DB >> 10981037

Review of "angiotensin genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II".

N J Schork1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10981037     DOI： 10.1007/s11906-999-0068-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  10 in total

1.  Getting the right drug into the right patient.

Authors:  A Marshall
Journal:  Nat Biotechnol       Date:  1997-11       Impact factor: 54.908

Review 2.  Laying the foundations for personalized medicines.

Authors:  A Marshall
Journal:  Nat Biotechnol       Date:  1997-10       Impact factor: 54.908

3.  Pharmacogenetics and drug metabolism.

Authors:  S Ball; N Borman
Journal:  Nat Biotechnol       Date:  1997-10       Impact factor: 54.908

4.  The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.

Authors: 
Journal:  JAMA       Date:  1992-03-04       Impact factor: 56.272

5.  The use of genetic information in large-scale clinical trials: applications to Alzheimer research.

Authors:  N J Schork; A B Weder
Journal:  Alzheimer Dis Assoc Disord       Date:  1996       Impact factor: 2.703

6.  The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group.

Authors: 
Journal:  Arch Intern Med       Date:  1990-01

7.  Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.

Authors: 
Journal:  Arch Intern Med       Date:  1997-03-24

8.  Molecular basis of human hypertension: role of angiotensinogen.

Authors:  X Jeunemaitre; F Soubrier; Y V Kotelevtsev; R P Lifton; C S Williams; A Charru; S C Hunt; P N Hopkins; R R Williams; J M Lalouel
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

9.  Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

Authors:  S C Hunt; N R Cook; A Oberman; J A Cutler; C H Hennekens; P S Allender; W G Walker; P K Whelton; R R Williams
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

Review 10.  Molecular genetics of human blood pressure variation.

Authors:  R P Lifton
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.